Citius pharmaceuticals to present at the noblecon18 investor conference on april 20, 2022

Cranford, n.j. , april 14, 2022 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products in oncology, anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapies, today announced that it will present at noblecon18, noble capital markets' 18th annual investor conference being held april 19-21, 2022.
CTXR Ratings Summary
CTXR Quant Ranking